Astria Therapeutics
ATXS
ATXS
62 hedge funds and large institutions have $14.2M invested in Astria Therapeutics in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 14 closing their positions.
Holders
62
Holders Change
+11
Holders Change %
+21.57%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
25
Increased
16
Reduced
14
Closed
14
Calls
$397K
Puts
$220K
Net Calls
+$177K
Net Calls Change
-$344K
Top Buyers
| 1 |
IC
1
Ikarian Capital
Dallas,
Texas
|
$1.39M |
| 2 |
2
Morgan Stanley
New York
|
$1.34M |
| 3 |
EP
3
Eversept Partners
New York
|
$1.12M |
| 4 |
OM
4
Opaleye Management
Boston,
Massachusetts
|
$402K |
| 5 |
5
State Street
Boston,
Massachusetts
|
$783K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
76
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
77
Alyeska Investment Group
Chicago,
Illinois
| – | – | – | – |
|
|
QCG
78
Quadrant Capital Group
Cincinnati,
Ohio
| $0 | 196 | +196 | New |
|